Armephaco JSC

Armephaco JSC EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is -12.51. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 40.07 — a change of -131.22% (lower).

EV/FCF

-12.51

YoY

-131.22%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Armephaco JSC is 2024 -12.51 . EV/FCF (Enterprise Value to Free Cash Flow) of Armephaco JSC was 2023 40.07 . It decreases by -131.22% lower compared to the previous year.

The Armephaco JSC EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2017
-148.61 VND
Jan 1, 2018
-41.56 VND
Jan 1, 2019
242.02 VND
Jan 1, 2020
-30.72 VND
Jan 1, 2021
8.10 VND
Jan 1, 2022
53.25 VND
Jan 1, 2023
40.07 VND
Jan 1, 2024
-12.51 VND
The Armephaco JSC EV/FCF history
YEAREV/FCFYoY
-12.51-131.22%
40.07-24.75%
53.25+557.19%
8.10-126.38%
-30.72-112.69%
242.02-682.35%
-41.56-72.03%
-148.61+4,060.79%
-3.57-90.31%
-36.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

EV/FCF (Enterprise Value to Free Cash Flow) of Armephaco JSC is -12.51 in 2024.

EV/FCF (Enterprise Value to Free Cash Flow) of Armephaco JSC changed from 40.07 to -12.51, representing a -131.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Armephaco JSC

All Key Metrics — Armephaco JSC